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Summary paragraph:  43 
Serotonin (5-hydroxytryptamine; 5-HT) is a neurotransmitter that has an essential role in the 44 
regulation of emotion. The precise circuits through which aversive states are orchestrated by 5-45 
HT, however, have not yet been defined. Here we show that 5-HT from the dorsal raphe nucleus 46 
(5-HTDRN) enhances fear and anxiety and activates a subpopulation of corticotropin-releasing 47 
factor (CRF) neurons in the bed nucleus of the stria terminalis (CRFBNST).  Specifically, 5-HTDRN 48 
projections to the BNST, via actions at 5-HT2C receptors (5-HT2CRs), engage a CRFBNST 49 
inhibitory microcircuit that silences anxiolytic BNST outputs to the ventral tegmental area 50 
(VTA) and lateral hypothalamus (LH). Further, we demonstrate that this CRFBNST inhibitory 51 
circuit underlies aversive behavior following acute exposure to selective serotonin reuptake 52 
inhibitors (SSRIs). This early aversive effect is mediated via the corticotrophin releasing factor 53 
type 1 receptor (CRF1R) given that CRF1R antagonism is sufficient to prevent acute SSRI-54 
induced enhancements in aversive learning. These results reveal an essential 5-HTDRN 55 
→CRFBNST circuit governing fear and anxiety and provide a potential mechanistic explanation 56 
for the clinical observation of early adverse events to SSRI treatment in some patients with 57 
anxiety disorders1,2.    58 
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In view of multiple converging lines of evidence pinpointing 5-HT as a critical 59 
neuromodulator of pathological fear learning3,4, we first interrogated the endogenous recruitment 60 
of the 5-HTDRN→BNST circuit by an aversive footshock stimulus. Using fluorogold to retrogradely 61 
label BNST-projecting 5-HT neurons in the DRN, we found that c-fos, an immediate early gene 62 
indicative of in vivo neuronal activation, was significantly elevated in 5-HTDRN→BNST neurons 63 
after footshock (Figure 1a-f). Using in vivo electrophysiology, we then probed the neuronal 64 
dynamics of the BNST during fear conditioning and recall and found evidence for engagement 65 
during both conditioning and recall (Extended Data Figure 1).  66 
To decipher the role of this 5-HTDRN→BNST circuit in aversive behavior, 67 
Channelrhodopsin2 (ChR2)-eYFP was selectively expressed in 5-HTDRN neurons through the 68 
delivery of a Cre-inducible viral vector in mice expressing Cre recombinase under the control of 69 
a serotonin transporter promoter (SertCre) for both in vivo and ex vivo analysis. We observed 70 
eYFP+ (5-HT) cell bodies in the DRN and eYFP+ fibers in both the dorsal and ventral aspects of 71 
the BNST (SertCre::ChR2DRN→BNST), confirming a direct projection of 5-HT neurons originating 72 
in the DRN to the BNST (Figure 1g-h)5. Optical stimulation of these fibers in BNST slices 73 
evoked 5-HT release, as measured by fast-scan cyclic voltammetry (FSCV) (Figure 1i-j). 74 
Furthermore, bath application of the SSRI fluoxetine reliably decreased the rate of 5-HT 75 
reuptake, confirming that photostimulation of SERT+ terminals in the BNST originating from 76 
the DRN induces 5-HT release (Figure 1k-l).  77 
 We next examined whether this 5-HTDRN→BNST circuit is functionally relevant for fear and 78 
anxiety-like behavior.  To investigate this, SertCre::ChR2DRN→BNST mice were implanted with 79 
bilateral optical fibers and photostimulated in the BNST (473 nm, 20 Hz) using a standard tone-80 
shock fear conditioning paradigm. Optogenetic stimulation of this pathway was paired with a 81 
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tone that co-terminated with a scrambled footshock. Cued fear was assessed 24 hours after, and 82 
contextual fear 48 hours after, the initial fear acquisition session (Figure 1m-n). While no 83 
changes were observed during fear acquisition, both cued and contextual fear recall were 84 
significantly heightened in photostimulated SertCre::ChR2DRN→BNST mice (Figure 1o-q).  We next 85 
assessed anxiety-like behavior using well-characterized assays, the elevated plus maze (EPM) 86 
and novelty-suppressed feeding (NSF) tests. Upon stimulation with light, SertCre::ChR2DRN→BNST 87 
mice exhibited enhanced anxiety-like behavior in both the EPM and NSF (Figure 1r-s and 88 
Extended Data Figure 2a-b). Importantly, photostimulation did not induce hypolocomotion in the 89 
EPM or open field tests nor did it alter home-cage feeding, thus confirming that hypophagia in 90 
the NSF assay was due to anxiety and not a reduction in appetitive drive (Extended Data Figure 91 
2c-e).  One potential explanation of these results is that terminal stimulation in the BNST 92 
produces antidromic spikes in DRN cell bodies that release 5-HT in other brain regions, which 93 
could be also be driving these behaviors. In light of this, we probed the mechanism more deeply 94 
using converging approaches. 95 
To determine a receptor target through which 5-HT is signaling in the BNST, we then 96 
examined the impact of optogenetically evoked 5-HTDRN release on postsynaptic neuronal 97 
excitability and found a 3.05 ± 0.59 mV depolarization that was blocked by a 5-HT2CR 98 
antagonist (Figure 1t-u). In contrast to previous reports demonstrating co-release of 5-HT and 99 
glutamate from DRN projections to the nucleus accumbens6, we did not observe any time-locked 100 
light-evoked EPSCs in the BNST (data not shown). These results indicate that 5-HTDRN→BNST 101 
projections have a predominantly excitatory effect that is dependent on 5-HT2CR signaling. To 102 
examine the role of 5-HT2CR containing neurons in anxiety-like behavior, we next took 103 
advantage of a Htr2cCre mouse line (Extended Data Figure 3a-b)7. Using Designer Receptors 104 
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Exclusively Activated by Designer Drugs (DREADDs)8, we found that activation of Gq signaling 105 
in 5-HT2CR-expressing neurons in the BNST significantly delayed the onset of feeding in the 106 
NSF assay without impacting home cage feeding behavior (Extended Data Figure 3c-g), thus 107 
phenocopying the effect observed with 5-HTDRN→BNST fiber stimulation during NSF. Taken 108 
together, these results provide converging evidence that activation of 5-HTDRN→BNST inputs 109 
elicits anxiety-like behavior via 5-HT2CR signaling.  110 
We then considered the neurochemical phenotype of these target 5-HTDRN→5-HT2CRBNST 111 
neurons and hypothesized that 5-HT via 5-HT2CR modulates the activity of neurons expressing 112 
the neuropeptide CRF.  This hypothesis was based upon a previous analysis of 5-HT2CR 113 
knockout mice, which exhibit an anxiolytic phenotype associated with a reduction of c-fos in 114 
CRFBNST neurons9. Initially, using CRF reporter mice to a priori select CRF neurons for 115 
recordings, we found a heterogeneous 5HT-induced response of CRFBNST (Extended Data Figure 116 
4a), with only a subset demonstrating a depolarization.  Consistent with this, double fluorescence 117 
in situ hybridization revealed that only a subset of  CRF neurons within the dorsal BNST (~70%) 118 
and ventral BNST  (~43%%) express 5-HT2CRs (Extended Data Figure 4b-d).  119 
While CRF signaling within the BNST is classically associated with anxiety-like 120 
behavior10,11, more recent studies using circuit-based tools have found that optogenetic 121 
stimulation of GABAergic projections (which include CRFBNST neurons) to the VTA are 122 
anxiolytic12. This led us to hypothesize the existence of functionally distinct subsets of CRFBNST 123 
neurons that gate different behaviors and are differentially sensitive to 5HT. We used fluorescent 124 
retrograde tracer beads to label CRFBNST neurons as VTA-projecting or non-VTA-projecting 125 
(Figure 2a) and found that VTA-projecting CRF neurons (CRFBNST→VTA neurons) were 126 
hyperpolarized by an average of 5.73 ± 1.24 mV and non-VTA-projecting CRF neurons were 127 
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depolarized by an average of 2.74 ± 0.39 mV during 5-HT bath application. Moreover, the 128 
excitatory response to 5-HT in non-VTA-projecting CRF neurons was reversed in the presence 129 
of a 5-HT2C receptor antagonist (Figure 2b). Furthermore, all CRFBNST→VTA neurons were non-130 
responsive to the 5-HT2R agonist meta-Chlorophenylpiperazine (mCPP), while all non-VTA 131 
projecting CRF neurons were depolarized by mCPP by an average of 3.78 ± 1.17 mV (Extended 132 
Data Figure 4e-h). These findings suggest an anatomically distinct response to 5-HT by different 133 
subsets of CRFBNST neurons.  The subset of CRFBNST neurons expressing 5-HT2CRs do not 134 
project to the VTA and are depolarized by 5-HT, whereas the CRFBNST→VTA neurons are 135 
hyperpolarized by 5-HT, via actions at another 5-HT receptor. 136 
To determine if this 5-HT-dependent mechanism extended to other anxiolytic efferents, 137 
we injected retrograde tracer beads into the lateral hypothalamus (LH) of CRF reporter mice and 138 
found 5-HT had similar bidirectional effects on non-LH and LH projecting CRFBNST neurons 139 
(Extended Data Figure 5a-c). Noting the functional similarities between these two populations, 140 
we used retrograde tracing to determine that roughly ~58% of CRFBNST neurons have projections 141 
to the LH or VTA (Extended Data Figure 5d-f). Notably, ~20-31% of these CRFBNST output 142 
neurons form parallel projections to these structures.   143 
In light of recent reports that CRFBNST neurons are exclusively GABAergic13, we 144 
hypothesized that non-VTA-projecting CRFBNST neurons may locally inhibit BNST→VTA 145 
neurons to promote fear and anxiety. To test this hypothesis, we injected CrfCre mice with a Cre-146 
inducible ChR2 into the BNST and retrograde tracer beads into the VTA. We then recorded 147 
light-evoked IPSCs from non-ChR2 (ChR2-negative, retrograde tracer-positive) VTA-projecting 148 
BNST neurons (Figure 2c). Photostimulation produced action potentials in CRFBNST neurons and 149 
light-evoked IPSCs in non-ChR2 VTA-projecting neurons, indicating that CRFBNST neurons form 150 
                                                                     5-HTDRN → CRFBNST circuit elicits fear and anxiety 
 
7
local GABAergic synapses with BNST neurons that project to the VTA.  Repeating these same 151 
experiments in CrfCRE::ChR2BNST mice with retrograde tracer beads in the LH, we found that we 152 
could light-evoke GABA currents in LH projecting neurons as well (Extended Data Figure 5g-i). 153 
Moreover, we observed that 5-HT increased GABAergic transmission on to BNST→VTA 154 
projecting neurons in a tetrodotoxin and 5-HT2CR antagonist dependent manner (Figure 2d-f and 155 
Extended Data Figure 5j-n).  Similar effects of 5-HT on GABAergic transmission were found in 156 
BNST→LH projecting neurons (Extended Data Figure 5o-v). Furthermore, slice recordings in a 157 
CRF reporter line indicates that 5-HT does not increase GABAergic transmission on to the 158 
general population of CRFBNST neurons nor does it directly excite non-CRF VTA projecting 159 
neurons (Extended Data Figure 6). The 5-HT2R agonist mCPP also increased GABAergic but 160 
not glutamatergic transmission in the BNST (Extended Data Figure 7).  Finally, to test if 161 
optically evoked 5-HT can inhibit BNST outputs to the VTA, we performed slice recordings in 162 
the BNST of SertCre::ChR2DRN→BNST mice and found that brief photostimulation of 5-HT 163 
terminals in the BNST increased sIPSCs on to VTA projecting BNST neurons in a manner 164 
similar to bath applied 5-HT (Extended Data Figure 8a-c). Together, these experiments indicate 165 
that CRFBNST neurons inhibit at least two major BNST outputs to the VTA and LH that are 166 
reported to be anxiolytic 12,14, providing mechanistic insight into the aversive actions of 5-HT 167 
signaling in the BNST. 168 
We next took advantage of an intersectional strategy for direct visualization of these non 169 
projecting, putatively local CRFBNST neurons15. By coupling retrograde Cre-dependence flpases 170 
(HSV-LSL1-mCherry-IRES-flpo) in the VTA and LH with INTRSECT(Creon/flpoff)-Chr2-eYFP 171 
in the BNST of Crfcre mice (CrfCre::Intrsect-ChR2BNST mice), we were able to genetically isolate 172 
non-VTA/LH projecting CRF neurons in the BNST. We also infused Cre-dependent HSV-173 
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mCherry vector in a subset of CrfCre::Intrsect-ChR2BNST mice as a control. In HSV-flp infused 174 
CrfCre::Intrsect-ChR2BNST mice, we observed a significant reduction in YFP+ cells in the ventral 175 
BNST (Extended Data Figure 8d-f), indicating that a large proportion of VTA and LH-projecting 176 
CRFBNST neurons are located in the ventral BNST. We also found that 5-HT robustly depolarized 177 
these CrfCre::Intrsect-ChR2BNST neurons compared to CRF neurons at large (Figure 2g-i). 178 
Furthermore, we observed light evoked IPSCs in the BNST of CrfCre::Intrsect-ChR2BNST mice, 179 
confirming local GABA release from these neurons (Extended Data Figure 8g).  These results 180 
support the existence of a separate population of local CRFBNST neurons that is excited by 5-HT 181 
and increases local GABAergic transmission in the BNST, distinct from a population of 182 
CRFBNST neurons that project to and release GABA in the VTA or the LH (Extended Data Figure 183 
8h-j). 184 
 To probe the translational relevance of these BNST microcircuits, we adopted a 185 
pharmacological approach using SSRIs. SSRIs represent one of the most widely used classes of 186 
drugs for psychiatric disorders.  One limitation of SSRIs is that acute administration can lead to 187 
negative behavioral states1,2, a finding that is recapitulated in rodent models3,16–20.  Importantly, 188 
the BNST has been demonstrated to be an anatomical site of action for some of the aversive 189 
actions of SSRIs in rodents4.  This provided the opportunity to test our model that 5-HT in the 190 
BNST drives aversive behavior through inhibition of BNST outputs to the VTA. We observed 191 
that an acute systemic injection of the SSRI fluoxetine increased GABAergic transmission on to 192 
VTA projecting neurons in the BNST (Figure 3a-d). We then interrogated the role of CRFBNST 193 
neurons in acute fluoxetine-enhanced anxiety using CrfCRE mice transduced in the BNST with the 194 
Cre-inducible Gi-coupled DREADD.  We found that acute fluoxetine potentiated anxiety-like 195 
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behavior, and this effect was blocked by chemogenetic inhibition of CRFBNST neurons (Figure 196 
3e-h).  197 
To evaluate directly whether endogenous 5-HT acts on CRFBNST neurons to enhance cued 198 
fear memory, we used the same chemogenetic approach to silence CRFBNST neurons during 199 
fluoxetine treatment and subsequent fear conditioning (Figure 3i). Chemogenetic inhibition of 200 
CRFBNST neurons also significantly attenuated fluoxetine-induced enhancement of cued fear 201 
recall, providing proof of concept that augmentation of 5-HT via acute SSRI treatment recruits 202 
CRFBNST neurons to enhance fear-related behavior (Figure 3j-k). Next, using connectivity based 203 
chemogenetic approaches; we tested whether inhibition of BNST outputs to the VTA and LH is a 204 
critical component of 5-HT→BNST-induced aversive states. We observed that activation of Gq 205 
signaling in VTA- and LH-projecting BNST neurons, targeted by HSV-Cre-eYFP infused in the 206 
VTA and LH and Cre-dependent Gq-coupled DREADD infused in the BNST 207 
(HSVCre::hM3DqBNST), significantly attenuated fluoxetine enhancement of cued fear recall 208 
(Figure 3l-o). Together, these data provide compelling evidence that acute fluoxetine engenders 209 
aversive behavior by recruiting CRF neurons in the BNST that in turn inhibit putative 210 
GABAergic (anxiolytic and stress buffering) outputs from the BNST to the VTA and LH. 211 
Pharmacological interventions that target this circuit may improve adverse symptoms during the 212 
initial weeks of SSRI treatment. Based on the critical role for CRFBNST neurons in fluoxetine 213 
induced aversive behavior, we examined the impact of a systemic CRF1R antagonist on SSRI 214 
enhancement of cued fear recall. Notably, blocking the CRF system reduced this aversive state 215 
and abolished the increase in sIPSCs in LH-projecting neurons in the BNST during bath 216 
application of 5-HT (Extended Data Figure 9). This provides translational evidence that CRF1R 217 
antagonists given in concert with SSRIs could be a promising treatment for anxiety disorders. 218 
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Taken together, these data reveal a discrete 5-HT responsive circuit in the BNST that 219 
underlies pathological anxiety and fear associated with a hyperserotonergic state (Extended Data 220 
Figure 10). SSRIs are currently a first-line treatment for anxiety and panic disorders but can 221 
acutely exacerbate symptoms, resulting in poor therapeutic compliance. Our results strongly 222 
implicate 5-HT engagement of a local BNST inhibitory microcircuit in acute SSRI induced 223 
aversive behaviors in rodents, and could potentially be involved in the  early adverse events seen 224 
in clinical populations, emphasizing the need to identify compounds that selectively target both 225 
genetically-defined and pathway-specific cell populations.   226 
 227 
  228 
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FIGURE LEGENDS 324 
Figure 1: Optogenetic identification of a 5-HTDRN→BNST projection that elicits anxiety and 325 
fear-related behavior. (a) Experimental timeline for c-fos labeling of 5-HTDRN→BNST neurons 326 
following an aversive footshock stimulus. (b) Representative images of fluorogold (blue), 327 
tryptophan hydroxylase (violet), and c-fos (green) staining in the DRN for 13 mice. Scale bars: 328 
100 µm. (c-f) Histograms depicting the number of double and triple labeled neurons in the DRN 329 
of naïve and shocked mice. (c) There were no significant differences in the number of BNST 330 
projecting 5-HTDRN neurons between groups. (d-f) Footshock lead to significant elevations in the 331 
number of c-fos+ (“activated”) 5-HT neurons (t11=2.975, p<0.05, Student’s unpaired two-tailed 332 
t-test, n=7 naïve and n=6 shock mice), c-fos+, fluorogold labeled neurons (t11=2.836, p<0.05, 333 
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Student’s unpaired two-tailed t-test, n=7 naïve and n=6 shock mice), and triple labeled neurons 334 
(t11=2.374, p<0.05, Student’s unpaired two-tailed t-test, n=7 naïve and n=6 shock mice). (g) 335 
Experimental configuration for light-evoked FSCV experiments in SertCre::ChR2DRN→BNST mice 336 
(h) Coronal images showing ChR2-YFP expression in soma of the DRN and axons of the BNST. 337 
Scale bars: 500 µm. (i) Representative color plot of 5-HT release to optical stimulation (blue bar, 338 
20 Hz 20 pulses) for 3 mice (j) Representative cyclic voltammogram at peak 5-HT (blue dashed 339 
line panel E) for 3 mice. (k) Representative Current vs. Time trace at baseline  (black) and 340 
following 10 µM fluoxetine (red) for 3 mice. (l) Clearance half-life of 5-HT at baseline (white 341 
bar) and following 10 µM fluoxetine (red bar). (t2=8.43, p<0.05, Student’s paired two-tailed t-342 
test, n = 3 slices from 3 mice) (m) SertCre mice were transduced in the DRN and implanted with 343 
bilateral optical fibers in the BNST. (n) Schematic of fear conditioning procedures in 344 
SertCre::ChR2DRN→BNST mice. (o-q) Photostimulation during fear acquisition had no effect on 345 
freezing behavior during fear learning but increased freezing during cued (t17=2.436, p<0.05, 346 
Student’s unpaired two-tailed t-test, n=10 control, n=9 ChR2) and contextual fear recall 347 
(t17=2.271, p<0.05, Student’s unpaired two-tailed t-test, n=10 control, n=9 ChR2). (r) Light 348 
delivery to the BNST reduced open arm time in the EPM (t15=2.79, p<0.05, Student’s unpaired 349 
two-tailed t-test, n=8 control, n=9 ChR2) and (s) increased latency to feed in the NSF (t17=2.19, 350 
p<0.05, Student’s unpaired two-tailed t-test, n=9 control, n=10 ChR2). (t) Action potentials 351 
generated by photostimulation in the DRN (5 Hz (top), 10 Hz (middle), 20 Hz (bottom), 473 352 
nm). (u) Depolarization in cells (t8=5.20, p<0.01, One-sample t-test, n=9 cells from 4 mice) after 353 
photostimulation in the BNST (5 Hz, 10 s, 473 nm) and blockade of this response by 5 µM RS 354 
102221 (t4=2.5, p>0.05, One-sample t-test, n=5 cells from 2 mice). Data are mean ± s.e.m. 355 
*P<0.05; **P<0.01; ***P<0.001. 356 
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 357 
Figure 2: Serotonin activates a local population of CRFBNST neurons that inhibits outputs to 358 
the midbrain.  (a) Recording scheme for CRF reporter mice injected with retrograde tracer 359 
beads in the VTA. (b) 5-HT depolarizes local CRF neurons (t5=7.06 , p<0.001, One-sample t-360 
test, n=6 cells from 4 mice) in the BNST while hyperpolarizing CRFBNST→VTA neurons (t6=4.64, 361 
p<0.01, One-sample t-test, n=7 cells from 6 mice). Non VTA projecting CRF neurons are 362 
hyperpolarized by 5-HT in the presence of the 5-HT2CR antagonist RS102221 (t4=4.74, p<0.01, 363 
One-sample t-test, n=5 cells from 3 mice) (ci-ii) Schematic depicting infusions and recording 364 
configuration for CrfCre::ChR2BNST mice injected with retrograde tracer beads in the VTA.  (ciii) 365 
Representative trace of light-evoked IPSC in beaded (i.e. VTA projecting), non-ChR2 expressing 366 
neurons in the BNST of CrfCre::ChR2 mice with retrograde tracer beads in the VTA (n=8 cells 367 
from 3 mice) and blockade of this response by GABAzine (F11,33=53.16, p<0.001, Repeated 368 
Measures One-way ANOVA, n=4 cells from 3 mice). (d) Recording scheme for C57BL/6 mice 369 
with retrograde tracer beads in the VTA or LH (e) Representative traces of sIPSCs in BNST 370 
neurons that project to the VTA before and after 5-HT application for 5 cells from 4 mice (f) Bar 371 
graphs showing magnitude of 5-HT effect on average sIPSC frequency in BNST neurons that 372 
project to the VTA (t4=3.257, p<0.05, One-sample t-test, n=5 cells from 4 mice) and in BNST 373 
neurons that project to the LH (t5=3.027, p<0.05, One-sample t-test, n=6 cells from 3 mice) and 374 
blockade of these responses by TTX and RS 102221. Effects on amplitude were non-significant. 375 
(g) Experimental scheme for experiments with CrfCre::Intrsect-ChR2BNSTmice. (h-i,) 5-HT 376 
significantly depolarizes non-projecting CRF (“Intrsect”) neurons in the BNST (t6=2.501, p < 377 
0.05, One-sample t-test, n=7 cells from 5 mice) and produces a significant change in membrane 378 
potential in CRF Intrsect neurons compared to all CRF neurons (t26=2.08, p<0.05, Student’s 379 
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unpaired two-tailed t-test, n=21 cells from 14 mice for experiments in all CRF neurons and n=7 380 
cells from 5 mice for CrfCre::Intrsect-ChR2BNST experiments). Data are mean ± s.e.m. *P<0.05; 381 
**P<0.01; ***P<0.001. # donates P<0.05 for the Student’s unpaired two-tailed t-test between all 382 
CRF neurons and CRF Intrsect neurons in panel 2h. 383 
 384 
Figure 3: Acute fluoxetine elicits aversive behavior by engaging inhibitory CRF circuits in 385 
the BNST. (a) Schematic of recording for in vivo fluoxetine experiments in CRF reporter mice. 386 
(b) Representative traces of sIPSCs in VTA projecting neurons in the BNST for 5 experiments in 387 
2 saline-treated mice and 7 experiments in 2 fluoxetine-treated mice. (c-d) Bar graphs showing 388 
that fluoxetine increases in sIPSC frequency (t10=2.55, p<0.05, Student’s unpaired two-tailed t-389 
test, n=5 cells from 2 saline-treated mice, n=7 cells from 2 fluoxetine-treated mice), but not 390 
amplitude (t10=0.4752, p>0.05, Student’s unpaired two-tailed t-test, n=5 cells from 2 saline mice, 391 
n=7 cells from 2 fluoxetine mice) in VTA projecting neurons in the BNST. (e) Experimental 392 
configuration for assessment of anxiety in fluoxetine-treated CrfCre::hM4DiBNST mice and a 393 
coronal slice of the BNST expressing hM4Di-mCherry. Scale bar: 100 µm. (f) Confirmatory 394 
electrophysiology in the BNST showing hyperpolarization of hM4Di-mCherry-expressing cells 395 
following bath application of CNO (t5=4.32, p<0.01, One-sample t-test, n=6 cells from 4 mice) 396 
(g-h) Chemogenetic silencing of CRF neurons attenuates fluoxetine-induced anxiety like 397 
behavior on the elevated zero maze (F1,30=7.086, p<0.05, Two-way ANOVA, n=10 398 
fluoxetine/hM4Di and n=8 for all other groups) without any concomitant locomotor effects. (i) 399 
Experimental configuration for fear conditioning experiments in CrfCre::hM4DiBNST mice. (j-k) 400 
Chemogenetic silencing of CRFBNST neurons had no effect on freezing behavior during fear 401 
learning but prevented fluoxetine enhancement of cued fear recall (F1,17=8.73, p<0.01, Two-way 402 
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ANOVA, n=6 mCherry/vehicle and n=5 per group for all other groups). (l) Experimental 403 
configuration for assessment of the role of BNST outputs to the VTA and LH in fluoxetine-404 
induced aversive behavior. (m) Confocal image of the BNST from HSVCre::hM3DqBNST mice. 405 
Scale bars: 500 µm.. (n-o) Chemogenetic activation of BNST neurons that project to the 406 
midbrain did not impact fear acquisition but attenuated fluoxetine induced enhancement of cued 407 
fear recall (F1,27=7.541, p<0.05, Two-way ANOVA, n=7 vehicle/hM3D and n=8 for all other 408 
groups). Data are mean ± s.e.m. *P<0.05; **P<0.01; ***P<0.001. 409 
 410 
METHODS 411 
Mice:  Mice were used in all experiments. For experiments involving Cre lines, mice were 412 
crossed for several generations to C57 mice before using. All wild-type mice were C57BL/6 413 
mice obtained from The Jackson Laboratory (Bar Harbor, ME). For all behavior experiments 414 
except those involving Htr2cCre mice, male mice ranging in age from 8-16 weeks were used. 415 
Female Htr2cCre mice were used in chemogenetic manipulations. Both male and female mice 416 
aged 6-20 weeks were used for slice electrophysiology and anatomical tracing experiments. All 417 
behavioral studies or tissue collection for ex vivo slice electrophysiology were performed during 418 
the light cycle. 419 
All behavioral experiments in Htr2ccre mice were conducted at the University of Aberdeen and in 420 
accordance with the United Kingdom Animals (Scientific Procedures) Act of 1986.  All in vivo 421 
electrophysiology experiments were conducted in accordance with all rules and regulations at the 422 
National Institute for Alcohol Abuse and Alcoholism at the National Institutes of Health.  All 423 
other procedures were conducted in accordance with the National Institutes of Health guidelines 424 
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for animal research and with the approval of the Institutional Animal Care and Use Committee at 425 
the University of North Carolina at Chapel Hill. 426 
All animals were group housed on a 12 hour light cycle (lights on at 7 a.m.) with ad libitum 427 
access to rodent chow and water, unless described otherwise. CRF-ires-Cre (Crfcre) were 428 
provided by Dr. Bradford Lowell (Harvard University) and were previously described21. 429 
C57BL/6J mice were obtained from the Jackson Laboratory (Bar Harbor, ME). To visualize 430 
CRF-expressing neurons, CrfCre mice were crossed with either an Ai9 or a cre-inducible L10-431 
GFP reporter line (Jackson Laboratory)22 to produce CRF-Ai9 or CRF-L10GFP progeny, 432 
referred to throughout the manuscript as CRF-reporters. SertCre mice (from GENSAT) were a 433 
generous gift from Dr. Bryan Roth. Htr2cCre mice were supplied by Dr. Lora Heisler and are 434 
described in detail elsewhere7. 435 
Male mice were used for in vivo optogenetic behavioral experiments and for assessing the 436 
involvement of BNST CRF neurons on fluoxetine-induced enhancement of fear. Female 5-HT2C-437 
Cre mice were used in chemogenetic manipulations. Both male and female mice were used for 438 
slice electrophysiology and anatomical tracing experiments. All behavioral studies or tissue 439 
collection for ex vivo slice electrophysiology were performed during the light cycle.  440 
Viruses and tracers: All AAV viruses except INTRSECT constructs were produced by the 441 
Gene Therapy Center Vector Core at the University of North Carolina at Chapel Hill and had 442 
titers of >1012 genome copies/mL. For ex vivo and in vivo optical experiments, mice were 443 
injected with rAAV5-ef1α-DIO-hChR2(H134R)-eYFP or rAAV5-ef1α-DIO-eYFP as a control. 444 
Red IX retrobeads (Lumafluor) were used to fluorescently label LH - and VTA-projecting BNST 445 
neurons during ex vivo slice electrophysiology recordings.  The retrograde tracer Fluoro-Gold 446 
(Fluorochrome) was used for anatomical mapping.  Choleratoxin B (CTB) 555  and CTB 657 447 
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retrograde tracers (Invitrogen; C34776, and C34778, respectively) diluted to 0.5% (w/v) in 448 
sterile PBS were used per injection site for anatomical mapping of collateral projections from 449 
BNST to LH and VTA. For chemogenetic manipulations, mice were injected with 400 nl of 450 
rAAV8-hsyn-DIO-hM3D(Gq)-mCherry, rAAV8-hsyn-DIO-hM4D(Gi)-mCherry, or rAAV8-451 
hsyn-DIO-mCherry bilaterally.  HSV-hEF1α-mCherry, HSV-ef1α-LSL1-mCherry-IRES-flpo, 452 
and HSV-ef1α-IRES-Cre (supplied by Rachel Neve at the McGovern Institute for Brain 453 
Research at MIT) were injected bilaterally into the VTA and LH at a volume of 500500 nL per 454 
sitesite. The INTRSECT construct AAVdj-hSyn-Con/Foff-hChR2(H134R)-EYFP was infused at 455 
500 nl per side into the BNST. All AAV constructs had viral titers >1012 genome particles/ml. 456 
Stereotaxic injections: All surgeries were conducted using aseptic technique. Adult mice (2-5 457 
months) were deeply anesthetized with 5% isoflurane (vol/vol) in oxygen and placed into a 458 
stereotactic frame (Kopf Instruments) while on a heated pad. Sedation was maintained at 1.5-459 
2.5% isoflurane during surgery. An incision was made down the midline of the scalp and a 460 
craniotomy was performed above the target regions and viruses and fluorescent tracers were 461 
microinjected using a Neuros Hamilton syringe at a rate of 100 nl/min. After infusion, the needle 462 
was left in place for 10 minutes to allow for diffusion of the virus before the needle was slowly 463 
withdrawn.  Injection coordinates (in mm, midline, Bregma, dorsal surface): BNST (±1.00, 0.30, 464 
-4.35), LH (±0.9 to 1.10, -1.7, -5.00 to -5.2), VTA (-0.3, -2.9, -4.6), DR (0.0, -4.65, -3.2 with a 465 
23ᵒ angle of approach). When using retrobeads, injection volumes into the LH and VTA were 466 
300 nl and 400 nl, respectively. Fluorogold injection volumes were 200 nl per target site. CTB 467 
volumes were 200200 nL per target site. An optical fiber was implanted in the BNST (±1.00, 468 
0.20, -4.15) at a 10ᵒ angle for in vivo photostimulation studies. After fiber implantation, dental 469 
cement was used to adhere the ferrule to the skull. Following surgery, all mice returned to group 470 
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housing. Mice were allowed to recover for at least 3 weeks before being used for chemogenetic 471 
behavioral studies, or 6 weeks for in vivo optogenetic studies.  472 
Drugs: RS 102221, 5-HT and mCPP were from Tocris (Bristol, UK). For electrophysiology 473 
experiments, RS 102221 was made up to 100 mM in DMSO and then diluted to a final 474 
concentration of 5 µM in aCSF. 5-HT and mCPP were stocked at 10 and 20 mM, respectively, in 475 
ddH2O and diluted to their final concentations in aCSF. For electrophysiology experiments, 476 
clozapine-N-oxide (CNO; from Dr. Bryan Roth) was stocked at 100 mM in DMSO and diluted 477 
to 10 µM in aCSF. For behavior experiments, CNO was dissolved in 0.5% DMSO (in 0.9% 478 
saline) to a concentration of 0.1 mg/ml or 0.3 mg/ml and injected at 10 ml/kg for a final 479 
concentration of 1 or 3 mg/kg, i.p. Fluoxetine (Sigma) was made up in 0.9% NaCl to a 480 
concentration of 1 mg/ml and then injected at 10 ml/kg for a final concentration of 10 mg/kg, i.p. 481 
In vivo Electrophysiological Procedures  482 
Surgical Procedures 483 
Mice were anesthetized with 2% Isoflurane (Baxter Healthcare, Deerfield, IL) and implanted 484 
with 2x8 electrode (35um tungsten) micro-arrays (Innovative Neurophysiology Inc, Durham, 485 
NC) targeted at the BNST (ML: 0.8 mm, AP: ± 0.5 mm , and DV: -4.15 mm relative to Bregma). 486 
Following surgery, mice were singly housed and allowed at least one week to recover prior to 487 
behavioral testing. 488 
Fear Conditioning 489 
Fear conditioning took place in 27 × 27 × 11cm conditioning chambers (Med Associates, 490 
St. Albans, VT), with a metal-rod floor (Context A) and scented with 1% vanilla. Mice received 491 
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5 parings of a pure tone CS with a .6mA foot shock.  24 h following conditioning, mice 492 
underwent a CS recall test (10 presentations of the CS alone, 5 sec ITI), which was conducted in 493 
a Plexiglas cylinder (20cm diameter) and scented with 1% acetic acid (Context B). Stimulus 494 
presentations for both tests were controlled by MedPC (Med Associates Inc, St. Albans, VT). 495 
Cameras were mounted overhead for recording freezing behavior, which was scored 496 
automatically using CinePlex Behavioral Research System software (Plexon Inc, Dallas, TX).  497 
Electrophysiological recording and single unit analysis  498 
Electrophysiological recording took place during both fear conditioning and CS recall tests. 499 
Individual units were identified and recorded using Omniplex Neural Data Acquisition System 500 
(Plexon Inc, Dallas, TX).  Neural data was sorted using Offline Sorter (Plexon Inc, Dallas, TX).  501 
Waveforms were isolated manually, using principal component analysis. To be included in the 502 
analyses, spikes had to exhibit a refractory period of at least 1 ms.  Autocorrelograms from 503 
simultaneously recorded units were examined to ensure that no cell was counted twice. Single 504 
units were analyzed by generating perievent histograms (3 sec bins) of firing rates from 30 sec 505 
prior to CS onset until 30 sec after CS offset (NeuroExplorer 5.0, Nex Technologies, Madison, 506 
AL). Firing rates were normalized to baseline (30 sec prior to CS onset) using z-score 507 
transformation. Analysis included a total of 139 cells over three days of recording. Data reported 508 
for raw firing rates include only putative principal neurons (<10Hz).  509 
The formula for computing the suppression ratio was (average freezing rate) / (average freezing 510 
rate + average movement rate). Each cell was calculated individually. A value of .5 = no change 511 
in rate). 512 
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Ex vivo Slice Electrophysiology: Brains were sectioned at 0.07 (mm/s) on a Leica 1200S 513 
vibratome to obtain 300 µm coronal slices of the BNST, which were incubated in a heated 514 
holding chamber containing normal, oxygenated aCSF (in mM:124 NaCl, 4.4 KCl, 2 CaCl2, 1.2 515 
MgSO4, 1 NaH2PO4, 10.0 glucose, and 26.0 NaHCO3) maintained at 30 ± 1˚C for at least 1 hour 516 
before recording. Slices were transferred to a recording chamber (Warner Instruments) 517 
submerged in normal, oxygenated aCSF maintained at 28-30˚C at a flow rate of 2 ml/min. 518 
Neurons of the BNST were visualized using infrared differential interference contrast (DIC) 519 
video-enhanced microscopy (Olympus). Borosilicate electrodes were pulled with a Flaming-520 
Brown micropipette puller (Sutter Instruments) and had a pipette resistance between 3-6 MΩ. 521 
Signals were acquired via a Multiclamp 700B ampliﬁer, digitized at 10 kHz and analyzed with 522 
Clampfit 10.3 software (Molecular Devices, Sunnyvale, CA, USA). 523 
Light-evoked action potentials: In SertCre or CrfCre mice, fluorescently labeled neurons 524 
expressing ChR2 were visualized and stimulated with a blue (470 nm) LED using a 1 Hz, 2 Hz, 5 525 
Hz, 10 Hz, and 20 Hz stimulation protocol with a pulse width of 0.5 ms.  Evoked action 526 
potentials were recorded in current clamp mode using a potassium gluconate based internal 527 
solution (in mM: 135 K+ gluconate, 5 NaCl, 2 MgCl2, 10 HEPES, 0.6 EGTA, 4 Na2ATP, 0.4 528 
Na2GTP, pH 7.3, 285–290 mOsmol). 529 
Light-evoked synaptic transmission: In CrfCre mice with ChR2 in the BNST and retrograde tracer 530 
beads in the VTA or LH, we visualized non-ChR2-expressing, beaded neurons using green (532 531 
nm) LED. Recordings were conducted in voltage clamp mode using a cesium-methansulfonate 532 
(Cs-Meth) based internal solution (in mM: 135 cesium methanesulfonate, 10 KCl, 1 MgCl2, 0.2 533 
EGTA, 2 QX-314, 4 MgATP, 0.3 GTP, 20 phosphocreatine, pH 7.3, 285–290 mOsmol) so that 534 
we could detect EPSCs (-55 mV) and IPSCs (+10 mV) in the same neuron. After confirming the 535 
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absence of a light-evoked EPSC signal, we measured light-evoked IPSCs during a single, 5 ms 536 
light pulse of 470 nm. In a subset of these experiments, SR95531 (GABAzine, 10 µM) was bath 537 
applied for 10 minutes to block IPSCs. 538 
Drug effects in CRFBNST neurons: Crf-reporter mice were injected with retrograde tracer beads 539 
into the VTA (ML -0.5, AP -2.9, DV -4.6). We then recorded from beaded (VTA-projecting) and 540 
non-beaded (non-projecting) CRF neurons in the BNST. Acute drug effects were determined in 541 
current clamp mode in the presence of TTX using a potassium gluconate-based internal solution. 542 
After a 5-minute stable baseline was established, 5HT (10 µM) or mCPP (20 µM) was bath 543 
applied for 10 minutes while recording changes in membrane potential. The difference in 544 
membrane potential between baseline and drug application at peak effect (delta or Δ MP) was 545 
later determined. In a subset of mCPP experiments, slices were incubated with RS 102221 (5 546 
µM) for at least 20 minutes before experiments began. 547 
Synaptic transmission: Spontaneous inhibitory postsynaptic currents (sIPSCs) were assessed in 548 
voltage clamp using a potassium-chloride gluconate-based intracellular solution (in mM: 70 KCl, 549 
65 K+-gluconate, 5 NaCl, 10 HEPES, 0.5 EGTA, 4 ATP, 0.4 GTP,  pH 7.2, 285–290 mOsmol). 550 
IPSCs were pharmacologically isolated by adding kynurenic acid (3 mM) to the aCSF to block 551 
AMPA and NMDA receptor-dependent postsynaptic currents. The amplitude and frequency of 552 
sIPSCs were determined from 2 minute recording episodes at -70 mV. The baseline was 553 
averaged from the 4 minutes preceding the application of 5-HT (10 µM) or mCPP (10 µM) for 554 
10 minutes. In a subset of these experiments, RS 102221 (5 µM) was added to the aCSF and 555 
slices were incubated in this drug solution for at least 20 minutes before experiments began. For 556 
miniature IPSCs (mIPSCs), TTX was included in the aCSF to block network activity. 557 
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In SertCre::ChR2BNST mice with retrograde tracer beads in the VTA, sIPSCs were recorded as 558 
described above. After achieving a stable baseline, a 10 s, 20 Hz photostimulation was applied.  559 
For assessment of spontaneous excitatory postsynaptic currents (sEPSCs), a cesium gluconate-560 
based intracellular solution was used (in mM:  135 Cs+-gluconate, 5 NaCl, 10 HEPES, 561 
0.6 EGTA, 4 ATP, 0.4 GTP, pH 7.2, 290–295 mOsmol). AMPAR-mediated EPSCs were 562 
pharmacologically isolated by adding 25 μM picrotoxin to the aCSF. sEPSC recordings were 563 
acquired in 2 minute recording blocks at -70 mV. 564 
Fast-scan cyclic voltammetry (FSCV): Electrodes were fabricated as previously described and 565 
cut to 50-100 um in length23. Animal and slice preparation were as described above for 566 
electrophysiology and slices were perfused on the rig in ACSF. Using a custom built potentiostat 567 
(University of Washington Seattle), 5-HT recordings were made in the BNST using TarHeel CV 568 
written in lab view (National Instruments). Briefly a triangular waveform (-0.1 V to 1.3 V with a 569 
10% phase shift at 1000 V/s, vs. Ag/AgCl) was applied to the carbon fiber electrode at a rate of 570 
10 Hz. Slices were optically stimulated with 20 5-ms blue (490 nm) light pulses at a rate of 20 571 
Hz down the submerged 40x objective. 10 cyclic voltammograms were averaged prior to optical 572 
stimulation for background subtraction.  Voltammograms were digitally smoothed one time with 573 
a fast Fourier transform following data collection and analyzed with HDCV (UNC Chapel Hill). 574 
Fluoxetine (10 µM) was bath applied following a stable baseline  (20 minutes).  575 
 576 
Behavioral Assays:  577 
For chemogenetic manipulations, mice were transported to a holding cabinet adjacent to the 578 
behavioral testing room to habituate for at least 30 minutes before being pretreated with CNO (3 579 
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mg/kg, i.p. for CrfCre mice and 1 mg/kg, i.p. for Htr2CCre mice). All behavior testing began 45 580 
minutes following CNO treatment, with the exception of fear conditioning training, which 581 
occurred 30 minutes after a CNO injection. When assessing the effect of fluoxetine on fear 582 
conditioning, fluoxetine (10 mg/kg, i.p.), or vehicle, was administered 1 hour before training (30 583 
minutes before CNO treatment). For optogenetic manipulations, mice received bilateral 584 
stimulation (473 nm, ~10 mW, 5 ms pulses, 20 Hz) when specified. Unless specified, all 585 
equipment was cleaned with a damp cloth between mouse trials. All sessions were video 586 
recorded and analyzed using EthoVision software (Noldus Information Technologies) except 587 
where noted.  588 
Elevated Plus Maze: Mice were placed in the center of an elevated plus maze and allowed to 589 
explore during a 5 minute session.  Light levels in the open arms were ~14 lux. During 590 
optogenetic manipulations mice received bilateral stimulation during the entire 5 minute session. 591 
Mice that left the maze were excluded from analysis (n= 2 control, 1 ChR2 from optogenetic 592 
experiments). 593 
Open Field: Mice were placed into the corner of a white Plexiglas open field arena (25 x 25 x 25 594 
cm) and allowed to freely explore for 30 minutes. The center of the open field was defined as the 595 
central 25% of the arena. For optogenetic studies the 30 minute session was divided into three 596 
10-minute epochs consisting of stimulation off, stimulation on, and stimulation off periods. 597 
Novelty-Induced Suppression of Feeding: 48 hours prior to testing mice were provided with 598 
access to a single piece of Froot Loops cereal (Kellogg’s) in their home cage. 24 hours prior to 599 
testing, home cage chow was removed and mouse body weights were recorded. Water remained 600 
available ad lib. Beginning at least one hour before testing mice transferred to new clean cages 601 
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so they were singly housed for the test session and body weights were recorded. During the test 602 
session mice were placed into an arena (25x25x25 cm) that contained a single Froot Loop on top 603 
of a piece of circular filter paper. Mice were monitored by a live observer and the latency for the 604 
mouse to begin eating the pellet was measured, allowing up to 10 minutes. All mice began eating 605 
within this time. Following the initiation of feeding, mice were removed from the arena and 606 
placed back into their home cages. Mice were then provided with 10 minutes of access to a pre-607 
weighed amount of Froot Loops™ for a post-test feeding session. After this 10 minute post-test, 608 
the remaining Froot Loops were weighed and mice were returned to ad lib home cage chow. 609 
Mice were returned to group housing at the end of this session. For optogenetic experiments, 610 
mice received constant 20 Hz optical stimulation during both the latency to feed assay and the 10 611 
minute post-test. During optogenetic experiments, one control mouse did not feed during the 10 612 
minute NSF session and was excluded from the results. 613 
Home cage feeding: SertCre mice were food deprived for 24 hours. On the day of the experiment, 614 
mice were acclimated to the behavior room for 1 hour. A single preweighed food pellet was 615 
placed in the home cage and the mice were allowed to eat for 10 minutes during optogenetic 616 
stimulation. At the end of the experimental session, the pellet was removed and weighed and 617 
mice were given ad lib access to food.  618 
Htr2CCre mice were acclimated in metabolic chambers (TSE Systems, Germany) for 2 days before 619 
the start of the recordings. After acclimation, mice were food deprived for 24 hours. Following 620 
fasting, mice received an IP injection of CNO 30 minutes before food presented again. Mice 621 
were recorded for 12 hours with the following measurements being taken every 30 minutes: 622 
water intake, food intake, ambulatory activity (in X and Z axes), and gas exchange (O2 and CO2) 623 
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(using the TSE LabMaster system, Germany). Energy expenditure was calculated according to 624 
the manufacturer’s guidelines (PhenoMaster Software, TSE Systems).  625 
Fear Conditioning: We used a three day protocol to assess both cued and contextual fear recall. 626 
On the first day, mice were placed into a fear conditioning chamber (Med Associates) that 627 
contained a grid floor and was cleaned with a scented paper towel (19.5% EtOH, 79.5% H2O, 628 
1% vanilla). After a 3 minute baseline period, mice were exposed to a 30 second tone (3 KHz, 80 629 
dB) that co-terminated with a 2 second scrambled foot shock (0.6 mA). A total of 5 tone-shock 630 
pairings were delivered with a random inter-tone interval (ITI) of 60-120 seconds. For 631 
optogenetic studies, light stimulation occurred only during the 30-second tones of this session. 632 
Following delivery of the last foot shock, mice remained in the conditioning chamber for a two 633 
minute consolidation period. 24 hours later, mice were placed into a separate conditioning box 634 
(Med Associates) that contained a white Plexiglas floor, a striped pattern on the walls, and was 635 
cleaned and scented with a 70% EtOH solution. After a 3 minute baseline period, mice were 636 
presented with 10 tones (30 seconds, 3 KHz, 80 dB) with a 5 second ITI. Mice remained in the 637 
chamber after the last tone for a two-minute consolidation period. 24 hours later (48 hours after 638 
training), mice were returned to the original training chamber for 5 minutes. For each session, 639 
freezing behavior was hand-scored every 5 seconds by a trained observer blinded to 640 
experimental treatment as described previously24. Freezing was defined as a lack of movement 641 
except as required for respiration.  642 
Immunohistochemistry and histology: All mice used for behavioral and anatomical tracing 643 
experiments were anesthetized with Avertin and transcardially perfused with 30 ml of ice-cold 644 
0.01M PBS followed by 30 ml of ice-cold 4% paraformaldehyde (PFA) in PBS. Brains were 645 
extracted and stored in 4% PFA for 24 hours at 4°C before being rinsed twice with PBS and 646 
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stored in 30% sucrose/PBS until the brains sank. 45 µm slices were obtained on a Leica VT100S 647 
and stored in 50/50 PBS/Glycerol at -20°C. DREADD or ChR2-containing sections were 648 
mounted on slides, allowed to dry, coverslipped with VectaShield (Vector Labs, Burlingame, 649 
CA), and stored in the dark at 4°C.  650 
Tryptophan hydroxylase/Fluorogold/cfos triple labeling We stained free-floating dorsal raphe 651 
sections using indirect immunofluorescence sequentially for first tryptophan hydroxylase (TPH) 652 
and Fluoro-Gold(FG) and then c-fos. For TPH/FG, we washed sections 3X for 5 min with 0.01 653 
M PBS, permeabilized them for 30 min in 0.5% Triton/0.01 M PBS, and washed the sections 654 
again 2X with 0.01 M PBS. We blocked the sections for 1 hour in 0.1% Triton/0.01 M PBS 655 
containing 10%(v/v) Normal Donkey Serum and 1%(w/v) Bovine Serum Albumin (BSA). We 656 
then added primary antibodies (1:500 Mouse anti-TPH [Sigma Aldrich T0678] and 1:3000 657 
Guinea Pig anti-Fluoro Gold [Protos Biotech NM101]) to blocking buffer and incubated the 658 
sections overnight at 4 degrees C. The next day, we washed the sections 3X for 5 min with 0.01 659 
M PBS, then incubated them with 1:500 with Alexa Fluor 647-conjugated Donkey anti-mouse 660 
and Alexa Fluor 488-conjugated Donkey anti-guinea pig secondary antibodies for 2 hr at RT, 661 
and washed the sections 4X for 5 min with 0.01 M PBS. We then proceeded directly to the c-fos 662 
tyramide signal amplification based immunofluorescent staining. We permeabilized the sections 663 
in 50% methanol for 30 min, then quenched endogenous peroxidase activity in 3% hydrogen 664 
peroxide for 5 min. Followed by two 10 min washes in 0.01 M PBS, we blocked the sections in 665 
PBS containing 0.3% Triton X-100 and 1.0 % BSA for 1 hour. c-fos primary antibody (Santa 666 
Cruz Biotechnology - sc-52) was added to sections at 1:3000 and sections were incubated for 48 667 
hours at 4 degrees. On day 3, we washed the sections in TNT buffer (0.1 M Tris-HCl pH 7.5, 668 
0.15 M NaCl, 0.05% Tween-20) for 10 min, blocked in TNB buffer (0.1 M Tris-HCl pH 7.5, 669 
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0.15 M NaCl, 0.5% Blocking reagent – PerkinElmer FP1020) buffer for 30 min. We then 670 
incubated the sections in secondary antibody (Goat anti-rabbit HRP-conjugated- PerkinElmer) 671 
1:200 in TNB buffer for 30 min., washed the sections in TNT buffer 4X for 5 min, and then 672 
incubated the sections in Cy3 dye diluted in TSA amplification diluents for 10 min. We washed 673 
the sections 2X in TNT buffer, mounted them on microscope slides. We coverslipped the slides 674 
using Vectashield mounting medium.  We acquired 4-5 2x4 tiled z-stack(5 optical slices 675 
comprising 7 µm total) images of the dorsal raphe from each naïve and shock mouse on a Zeiss 676 
800 Upright confocal microscope. Scanning parameters and laser power were matched between 677 
groups. Images were preprocessed using stitching and maximum intensity projection and then 678 
analyzed using an advanced processing module in Zeiss Zen Blue that allows nested analysis of 679 
multiple segmented fluorescent channels within parent classes. Double and triple-labeled cells 680 
were validated in a semi-automated fashion. At least 4 sections per mouse were counted in this 681 
way. One mouse was identified as a significant outlier in the Shock group and was excluded 682 
from further analysis. 683 
SertCre::ChR2, and CrfIntrsect-ChR2 validation: To verify expression of ChR2-expressing fibers in 684 
the BNST originating from DR serotonergic neurons, 300 µm slices used for ex vivo 685 
electrophysiological recordings containing the DR and BNST were stored in 4% 686 
paraformaldehyde at 4°C for 24 hours before being rinsed with PBS, mounted, and coverslipped 687 
with Vectashield mounting medium. Images showing eYFP fluorescence from the DR and 688 
BNST were obtained on a Zeiss 800 upright confocal microscope using a 10x objective and tiled 689 
z stacks. To validate the INTRSECT construct, mice received injections of HSV-hEF1α-690 
mCherry or HSV-ef1α-LSL1-mCherry-IRES-flpo to both the LH and VTA bilaterally (N=4 and 691 
5, respectively). Both groups received AAVDJ-hSyn-Cre-on/Flp-off-hChR2(H134R)-EYFP to 692 
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the BNST bilaterally. Six weeks following injection, mice were perfused and tissue was 693 
collected as described above. To visualize YFP expression in the BNST of CrfCre::IntrsectBNST 694 
mice, free floating slices containing the BNST were rinsed three times with PBS for 5 minutes 695 
each. Slices were then incubated in 50% methanol for 30 minutes then incubated in 3% hydrogen 696 
peroxide for 5 minutes. Following three 10-minute washes in PBS, slices were incubated in 0.5% 697 
Triton X-100 for 30 minutes followed by a 10 minute PBS wash. Slices were blocked in 10% 698 
normal donkey serum/0.1% Triton X-100 for 1 hour, and then they were incubated overnight at 699 
4°C with a primary chicken anti-GFP antibody (GFP-1020, Aves) at 1:500 in blocking solution. 700 
Following primary incubation, slices were rinsed three times with 0.01M PBS for 10 minutes 701 
each and incubated with a fluorescent secondary antibody (AlexaFluor 488 Donkey anti-chicken) 702 
at 1:200 in PBS for 2 hours at room temperature. Slices were then rinsed with four 10-minute 703 
PBS washes before being mounted onto glass slides and coverslipped with Vectashield with 704 
DAPI. A 3x4 tiled z stack (7 optical sections comprising 35 µm total) image from both the left 705 
and right hemispheres of the BNST was obtained at 20x magnification using a Zeiss 800 upright 706 
confocal microscope. Scanning parameters and laser power were matched between groups. 707 
Images were preprocessed using stitching and maximum intensity projection. The number of 708 
fluorescent cells in the dorsal and ventral aspects of the BNST were counted by a blinded scorer 709 
using the cell counter plug-in in FIJI (ImageJ). Each hemisphere was considered independently 710 
per mouse. One mouse in the flp-expressing group was a significant outlier for number of cells 711 
expressed in a ventral BNST hemisphere (ROUT, Q=0.1%) and all data from that mouse were 712 
excluded.   713 
Choleratoxin retrograde tracer studies in CRF reporter mice: 3 male CRF-L10a reporter mice 714 
were injected with 200 nl of CTB 555 and CTB 647 bilaterally to the LH and VTA, respectively, 715 
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as described above. 5 days following injection, mice were perfused as described above, the 716 
brains were extracted, and were stored in 4% paraformaldehyde for 24 hours at 4°C before being 717 
rinsed with PBS and transferred to 30% sucrose until the brains sank. 45 µm sections containing 718 
the BNST were collected as described above. Sections containing the BNST were mounted on 719 
glass slides and coverslipped using Vectashield. An image from the left and right hemispheres of 720 
a medial section of the BNST was obtained on a Zeiss 800 upright microscope using a 20x 721 
objective and 3x5 tiled z stacks (5 optical slices comprising 7 µm total). Images were 722 
preprocessed using stitching and maximum intensity projection, and were then analyzed using 723 
the cell counter function in FIJI (ImageJ). Only cells positive for GFP (putative CRF neurons) 724 
were considered. Cells were scored exclusively as either 555+ only (LH-projecting), 647+ only 725 
(VTA-projecting), 555+ and 647+ (projecting to both LH and VTA), or 555- and 647- 726 
(unlabeled; neither LH- nor VTA- projecting). The total number of CRF neurons scored was 727 
calculated as the sum of all four groups, and percentages of each type were calculated from this 728 
value. Each hemisphere was scored and plotted independently (N=6 images from 3 mice), and 729 
the dorsal and ventral BNST were considered separately. The average values were plotted as pie 730 
charts (ED 9). 731 
Double Fluorescence in situ hybridization (FISH): For validation of 2C-cre line and 732 
comparison of CRF/2C mRNA cellular colocalization, mice were anesthetized using isoflurane, 733 
rapidly decapitated, and brains rapidly extracted. Immediately after removal, the brains were 734 
placed on a square of aluminum foil on dry ice to freeze. Brains were then placed in a -80°C 735 
freezer for no more than 1 week before slicing. 12 µm slices were made of the BNST on a Leica 736 
CM3050S cryostat (Germany) and placed directly on coverslips. FISH was performed using the 737 
Affymetrix ViewRNA 2-Plex Tissue Assay Kit with custom probes for CRF, 5-HT2C, and Cre 738 
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designed by Affymetrix (Santa Clara, CA). Slides were coverslipped with SouthernBiotech 739 
DAPI Fluoromount-G. (Birmingham, AL). 3x5 tiled z stack (15 optical sections comprising 14 740 
µm total) images of the entire 12 µm slice were obtained on a Zeiss 780 confocal microscope for 741 
assessment of CRF/2C colocalization. A single-plane 40x tiled image of a CRF/2C slice was 742 
obtained on a Zeiss 800 upright confocal microscope for the magnified image shown in Extended 743 
Data 6b, right.  3x5 tiled z stack (7 optical sections comprising 18 µm) images of 2C/Cre slices 744 
were obtained on a Zeiss 800 upright confocal microscope for the 2C/Cre validation. All images 745 
were preprocessed with stitching and maximum intensity projection. An image of the BNST 746 
from 3 mice in each condition was hand counted for each study using the cell counter plugin in 747 
FIJI (ImageJ). Cells were classified into three groups: probe 1+, probe 2+, or probe 1 and 2 +. 748 
Only cells positive for a probe were considered. Results are plotted as average classified 749 
percentages across the three images.  750 
Group assignment: No specific method of randomization was used to assign groups. Animals 751 
were assigned to experimental groups so as to minimize the influence of other variables such as 752 
age or sex on the outcome.  753 
Inclusion/exclusion criteria: Pre-established criteria for excluding mice from behavioral 754 
analysis included 1) missed injections, 2) anomalies during behavioral testing, such as mice 755 
falling off the elevated plus maze, 3) damage to or loss of optical fibers, 4) statistical outliers, as 756 
determined by the Grubb’s test.  757 
Sample size: A power analysis was used to determine the ideal sample size for behavior 758 
experiments. Assuming a  normal distribution, a 20% change in mean and 15% variation, we 759 
determined that we would need 8 mice per group. In some cases, mice were excluded due to 760 
                                                                     5-HTDRN → CRFBNST circuit elicits fear and anxiety 
 
34
missed injections or lost optical fibers resulting in fewer than 8 mice per group. For 761 
electrophysiology experiments, we aimed for 5-7 cells from 3-4 mice.  762 
Statistics: Data are presented as means ± SEM. For comparisons with only two groups, p values 763 
were calculated using paired or unpaired t-tests as described in the figure legends. Comparisons 764 
across more than two groups were made using a one-way ANOVA, and a two-way ANOVA was 765 
used when there was more than one independent variable. A Bonferonni posttest was used 766 
following significance with an ANOVA. In cases in which ANOVA was used, the data met the 767 
assumptions of equality of variance and independence of cases. If the condition of equal 768 
variances was not met, Welch’s correction was used. Some of the sample groups were too small 769 
to detect normality (<8 samples) but parametric tests were used because nonparametric tests lack 770 
sufficient power to detect differences in small samples (Graphpad Statistics Guide – 771 
www.graphpad.com). The standard error of the mean is indicated by error bars for each group of 772 
data. Differences were considered significant at p values below 0.05. All data were analyzed 773 
with GraphPad Prism software. 774 
21. Krashes, M. J. et al. An excitatory paraventricular nucleus to AgRP neuron circuit that 775 
drives hunger. Nature 507, 238–42 (2014). 776 
22. Madisen, L. et al. A robust and high-throughput Cre reporting and characterization 777 
system for the whole mouse brain. Nat. Neurosci. 13, 133–140 (2010). 778 
23. Bath, B. D. et al. Subsecond adsorption and desorption of dopamine at carbon-fiber 779 
microelectrodes. Anal. Chem. 72, 5994–6002 (2000). 780 
24. Hefner, K. et al. Impaired fear extinction learning and cortico-amygdala circuit 781 
abnormalities in a common genetic mouse strain. J. Neurosci. 28, 8074–8085 (2008). 782 
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EXTENDED DATA FIGURE LEGENDS 784 
Extended Data Figure 1: In vivo recordings in BNST neurons during fear conditioning 785 
reveal opposite patterns of activation during acquisition and recall. (a) Representative 786 
neuron firing rate and (b) population Z score of the firing rate for BNST neurons (n=45 cells 787 
from 7 mice) 30 s before conditioned stimulus (tone), during the conditioned stimulus, and 30 788 
seconds after the unconditioned stimulus. (c) Percentage time spent freezing during fear 789 
acquisition, cued fear recall and contextual fear recall. (d) Electrode placements for BNST 790 
recordings. (e) Raw firing rates during freezing (blue) versus movement (red) epochs were 791 
averaged across all putative principal neurons (firing rate <10Hz). Acquisition: Cells in BNST 792 
exhibited greater average firing rates during freezing epochs compared to movement epochs 793 
during CS3 (t44=2.88, p<0.01, Student’s unpaired two-tailed t-test), 4 (t44=3.14, p<0.01, 794 
Student’s unpaired two-tailed t-test), and 5 (t44=4.4, p<0.001, Student’s unpaired two-tailed t-795 
test) (n=45 cells from 7 mice). CS Recall: Average firing rates during freezing epochs decreased 796 
over CS presentations such that firing during block 5 was significantly less than block 1 797 
(t41=3.44, p=0.001, Student’s unpaired two-tailed t-test). Freezing firing rates during block 5 798 
were also significantly less than movement epochs during block 5 (t41=4.03, p<0.001, Student’s 799 
unpaired two-tailed t-test) (n=42 cells from 7 mice).  CX test: Average firing rate was 800 
significantly greater during movement versus freezing epochs during minutes 1 (t44=4.83, 801 
p<0.001, Student’s unpaired two-tailed t-test), 2 (t44=3.17, p<0.01, Student’s unpaired two-tailed 802 
t-test), and 5 (t44=4.36, p<0.001, Student’s unpaired two-tailed t-test) (n=45 cells from 7 mice). 803 
(f) Freezing-related changes in firing rates during the CS were determined by measuring the ratio 804 
of average firing rates during freezing versus movement epochs for each session. Acquisition: 805 
Activity during freezing epochs increased significantly relative to movement epochs during CS4 806 
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(t45=3.26, p<0.01, Student’s unpaired two-tailed t-test) and CS5 (t45=2.17, p<0.05, Student’s 807 
unpaired two-tailed t-test) (n=46 cells from 7 mice). CS Recall: Freezing significantly 808 
suppressed activity relative to movement epochs during the last two CS presentations (t47=5.29, 809 
p=<0.001, Student’s unpaired two-tailed t-test) (n=48 cells from 7 mice) CX test: Freezing 810 
significantly suppressed activity during minutes 1 (t44=6.06, p<0.001, Student’s unpaired two-811 
tailed t-test), 2 (t44=2.92, p<0.01, Student’s unpaired two-tailed t-test), and 5 (t44=3.55, p=.001, 812 
Student’s unpaired two-tailed t-test) (n=45 cells from 7 mice). (g) Plots showing correlation 813 
between freezing behavior and firing rate of BNST neurons across sessions and for all sessions. 814 
Data are mean ± s.e.m. *P<0.05 **P<0.01; ***P<0.001. Scale bar = 100 µm. 815 
 816 
Extended Data Figure 2: Effects of optogenetic stimulation of 5HT inputs to the BNST on 817 
feeding, anxiety and locomotion. (a-c) SertCre::ChR2DRN→BNST mice exhibited reduced 818 
probability (t15=2.67, p<0.05, Student’s unpaired two-tailed t-test, n=8 control, n=9 ChR2) and 819 
latency (t15=1.003, p>0.05, Student’s unpaired two-tailed t-test, n=8 control, n=9 ChR2) to enter 820 
the open arms of the EPM without exhibiting locomotor deficits. (d) Photostimulation of 5-821 
HTDRN→BNST terminals had no effect on locomotor activity in the open field (n=9 control, n=11 822 
ChR2) or (e) home cage feeding (n=4 control, n=6 ChR2). Data are mean ± s.e.m. *P<0.05. 823 
 824 
Extended Data Figure 3: Chemogenetic activation of 5-HT2CR expressing neurons in the 825 
BNST increases anxiety-like behavior. (a) Confocal images of coronal BNST slices obtained 826 
from htr2cCre mice following double fluorescence in situ hybridization for 5-HT2CR and cre.  827 
Yellow arrows indicate cells in which there is colocalization, red arrows indicate cells in which 828 
only Cre is expressed and green arrows indicate cells in which only 5-HT2CR is expressed.  (b) 829 
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Pie chart representing the distribution of genetic markers in BNST neurons. (c) Experimental 830 
configuration in Htr2ccre::hM3DqBNST mice. (d) Coronal images showing cfos induction in 5-831 
HT2CR expressing neurons in the BNST of Htr2cCre::hM3DqBNST or Htr2cCre::mCherryBNST mice 832 
following CNO injection. (e) Bath application of CNO depolarized 5HT2CR-expressing neurons 833 
expressing hM3Dq in slice (n=3 cells from 3 mice). (f) Chemogenetic stimulation of 5-HT2CR 834 
expressing neurons in BNST increased latency to feed in the NSF (t11=2.591, p<0.05, Student’s 835 
unpaired two-tailed t-test, n=6; mCherry, n=7 hM3Dq). (g) Chemogenetic activation of 5-836 
HT2CR-expressing BNST neurons had no effect on home cage feeding (n=5 mCherry, n=6 837 
hM3Dq). (h) Confocal images from Htr2cCre::mCherryBNST mice showing mCherry expression in 838 
5-HT2CR-expressing soma in the BNST and fibers in the LH and VTA. Data are mean ± s.e.m. 839 
*P<0.05. Scale bar = 100 µm. 840 
 841 
Extended Data Figure 4: Electrophysiological characterization of 5-HT responses and 5-842 
HT receptor expression in CRFBNST neurons (a) A pie chart showing the distribution of 843 
CRFBNST neurons that were depolarized, hyperpolarized, or had no response to 5-HT (n=8 cells 844 
from 4 mice). (b) Coronal images of the BNST showing colocalization of 5-HT2CRs with CRF 845 
mRNA using double fluorescence in situ hybridization and (c-d) histograms showing the % of 5-846 
HT2C neurons that express CRF and the % of CRF neurons that express 5-HT2CRs in the BNST 847 
(n=3 slices from 3 mice). (e) Recording configuration in CRFBNST neurons. (f) Slice 848 
electrophysiology in BNST of Crf reporter mice showing depolarization of all (VTA-projecting 849 
and non-projecting) CRF neurons following bath application of the 5-HT2 receptor agonist 850 
mCPP (n=12 cells from 6 mice) and blockade of this response by the 5-HT2C receptor antagonist 851 
RS 102221 (n=5 cells from 3 mice). (g) Change in membrane potential induced by mCPP 852 
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(t12=2.18, p<0.05, One-sample t-test, n=12 cells from 6 mice) is blocked by a 5-HT2CR 853 
antagonist (n=5 cells from 3 mice). (h) mCPP selectively depolarizes non-VTA projecting 854 
CRFBNST neurons (n=3 cells from 2 mice non VTA-projecting CRF, n=5 cells from 4 mice VTA-855 
projecting CRF). Data are mean ± s.e.m. *P<0.05. 856 
 857 
Extended Data Figure 5: 5-HT activates inhibitory microcircuits in the BNST that 858 
modulate outputs to the LH. (a) Recording configuration in CRF reporter mice infused with 859 
retrograde tracer beads in the LH. (b) Average traces of 5-HT induced depolarization in LH 860 
projecting vs non-projecting neurons (c) Histograms showing 5-HT induced depolarization in 861 
non-LH projecting BNST neurons (t4=4.425, p<0.05, One-sample t-test, n=5 cells from 3 mice) 862 
and hyperpolarization in LH-projecting neurons (t5=2.789, p<0.05, One-sample t-test, n=6 cells 863 
from 3 mice). (d) Confocal image of retrogradely CTB-labeled VTA (red) and LH (green) 864 
outputs in a CRF-L10a reporter (blue). (e-f) Pie charts depicting the percentage of LH-projecting 865 
only, VTA-projecting only, collateralizing, and CTB-negative (unlabeled) CRF in neurons in the 866 
dorsal and ventral aspects of the BNST (n=6 hemispheres from 3 mice). (g) Experimental 867 
schematic depicting viral infusions into the BNST and retrograde tracer bead infusions into the 868 
LH of CrfCre::ChR2BNST mice. (h) Recording configuration in CrfCre::ChR2BNST mice with LH 869 
tracer beads (i) Representative trace of light evoked IPSCs in LH projecting neurons (n=7 cells 870 
from 4 mice) and blockade of this light evoked response by GABAzine (n=2 cells from 2 mice). 871 
(j) Recording configuration in VTA projecting neurons in the BNST of C57BL/6 mice. (k-l) 5-872 
HT has no effect on miniature IPSC frequency or amplitude in BNST→VTA projecting neurons 873 
(n=7 from 4 mice). (m-n) 5-HT has no effect on sIPSC frequency or amplitude in the presence of 874 
the 5-HT2CR antagonist RS102221 (n=5 cells from 4 mice). (o) Recording configuration in LH 875 
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projecting neurons in the BNST of C57BL/6 mice (p) Representative traces showing an increase 876 
in sIPSC frequency in the presence of 5-HT for 6 cells from 3 mice (q-r) 5-HT increases sIPSC 877 
frequency but not amplitude in BNST→LH projecting neurons (F11,55=11.65, p<0.01, Repeated 878 
measures one-way ANOVA, n=6 cells from 3 mice). (s-t) 5-HT has no effect on miniature IPSC 879 
frequency or amplitude (n=5 cells from 3 mice). (u-v) 5-HT has no effect on sIPSC frequency or 880 
amplitude in the presence of RS102221 (n=6 cells from 4 mice). Data are mean ± s.e.m. 881 
*P<0.05. 882 
 883 
Extended Data Figure 6: 5-HT does not alter GABAergic transmission in CRF neurons nor 884 
does it directly excite non-CRF VTA projecting neurons in the BNST. (a) Recording 885 
configuration in CRFBNST neurons in a CRF reporter. (b-c) 5-HT has no effect on sIPSC 886 
frequency or amplitude in the total population of CRF neurons (n=5 cells from 3 mice). (d) 887 
Recording configuration in non-CRF, VTA projecting neurons in the BNST and average trace of 888 
5-HT effect on membrane potential in non-CRF, VTA projecting neurons in the presence of 889 
TTX. (e) Histogram summarizing 5-HT effects on membrane potential in local and VTA 890 
projecting CRF neurons and local CRF neurons in the presence of the 5-HT2C receptor antagonist 891 
RS102221 (same data shown in Figure 2b) juxtaposed with the lack of effect of 5-HT on 892 
membrane potential in non-CRF, VTA projecting neurons (t4=0.9381, ns, One-sample t-test, n=5 893 
cells from 3 mice). Data are mean ± s.e.m. **P<0.01; ***P<0.001. 894 
 895 
Extended Data Figure 7: The 5-HT2 agonist mCPP increases GABAergic but not 896 
glutamatergic transmission in the BNST. (a-b) mCPP increases sIPSC frequency 897 
(F15,30=1.863, p<0.001, Repeated measures one-way ANOVA, n=3 cells from 3 mice) but not 898 
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amplitude in the BNST of C57BL/6 mice. (c-d) mCPP has no effect on sEPSC frequency or 899 
amplitude in the BNST of C57BL/6 mice (n=5 cells from 3 mice). Data are mean ± s.e.m. 900 
*P<0.05. 901 
 902 
Extended Data Figure 8: Optogenetic and Intrsectional characterization of 5-HT-CRF 903 
circuits in the BNST and outputs to the midbrain (a) Experimental design and recording 904 
configuration from SertCre::ChR2DRN→BNST mouse with retrograde tracer beads in the VTA. (b) 905 
Representative traces for 5 cells from 3 mice depicting the increase in sIPSCs in VTA projecting 906 
neurons in the BNST following light-evoked 5-HT release (c) Histogram summarizing the effect 907 
of light evoked 5-HT release on sIPSC frequency in VTA projecting neurons  (t4=4.890, p<0.01, 908 
One-sample t-test, n=5 cells from 3 mice). (d) Experimental configuration in CrfCre::Intrsect-909 
ChR2BNST mice. (e) Representative images from 4 CrfCre::HSV-LSL1-mCherry-flpoVTA/LH mice 910 
and 4 CrfCre::HSV-LSL1-mCherryVTA/LH mice injected with Intrsect-ChR2-eYFP in the BNST. 911 
(f) Cell counts of eYFP+ neurons from HSV-LSL1-flpo and HSV-LSL1-mCherry injected 912 
CrfCre::Intrsect-ChR2BNST mice indicating the number of non-projecting CRF neurons compared 913 
to the total CRF population in the dorsal (top panel; t14=1.959, ns, Student’s unpaired two-tailed 914 
t-test, n=4 mice, 8 hemispheres per group) and ventral aspects of the BNST (bottom panel; 915 
t7=2.431, p<0.05, Student’s unpaired Welch’s corrected two-tailed t-test, n=4 mice, 8 916 
hemispheres per group)  (g) Recording configuration and light evoked IPSC showing local 917 
GABA release from non-projecting CRF neurons in the BNST. (h) Sterotaxic injection of ChR2 918 
in Crfcre mouse (i-j) Light evoked IPSCs in the VTA and LH indicating that CRF projections to 919 
these regions are GABAergic. Data are mean ± s.e.m. *P<0.05; **P<0.01. 920 
 921 
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Extended Data Figure 9: Pharmacological blockade of CRF1 receptors reduces fluoxetine 922 
induced aversive behavior and 5-HT enhancement of GABAergic transmission in the 923 
BNST. (a) Experimental schedule of injections and behavior. (b) CRF1R antagonist does not 924 
modify fear acquisition but reduces fluoxetine enhancement of cued fear recall (F1,20=13.70, 925 
p<0.01, Two-way ANOVA, n=6 per group). (c) Recording configuration in BNST neurons that 926 
project to the LH in C57BL/6 mice. (d) Bath application of a CRF1R antagonist blocks the 5-HT 927 
induced increase in sIPSC frequency in LH projecting neurons in the BNST (F10,30=0.2213, ns, 928 
Repeated measures one-way ANOVA, n=4 cells from 2 mice). (e) There was a reduction in 929 
sIPSC amplitude during 5-HT bath application and CRF1R blockade (F10,30=2.941, p<0.05, 930 
Repeated measures one-way ANOVA, n=4 cells from 2 mice). Data are mean ± s.e.m. **P<0.01. 931 
 932 
Extended Data Figure 10: Model of a serotonin-sensitive inhibitory microcircuit in the 933 
BNST that modulates anxiety and aversive learning. Serotonin inputs to the BNST activate 5-934 
HT2CRs expressed in non-projecting “local” CRF neurons. These “local” CRF neurons promote 935 
anxiety and fear by inhibiting anxiolytic outputs to the VTA and LH that are putatively 936 
GABAergic. Another discrete subset of CRF neurons, which are inhibited by 5-HT, send direct, 937 
inhibitory projections to the VTA and LH. These CRFBNST output neurons are GABAergic and 938 
putatively anxiolytic and stress buffering. Blue dashed lines indicate hypothesized additional 939 
synapses between CRFBNST neurons. Dashed red line indicates a putatively GABAergic synapse. 940 
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